Followup to:
Since the upward trendline broke - it now has become more of a support.
Possible Catalysts by End of January to assist this breakout:
1.) Update from NASDAQ meeting held this month (as to whether an extension to April will be given).
Possible Catalysts by March:
2.) Update regarding FDA Amendment that was sought after regarding Feb 2017 decision to discontinue trial. This news might take sometime depending on results / urgency.
Possible Catalysts anticipated by April to May:
3.) Preliminary results for ARGS-003 and ARGS-004 trials.
Possible Catalysts by End of January to assist this breakout:
1.) Update from NASDAQ meeting held this month (as to whether an extension to April will be given).
Possible Catalysts by March:
2.) Update regarding FDA Amendment that was sought after regarding Feb 2017 decision to discontinue trial. This news might take sometime depending on results / urgency.
Possible Catalysts anticipated by April to May:
3.) Preliminary results for ARGS-003 and ARGS-004 trials.
